Pividl Bioscience logo — A nanobiotechnology firm pioneering patented platform techno...

Pividl Bioscience

A nanobiotechnology firm pioneering patented platform technologies for diverse applications in health, wellness, consumer goods, agrifood, and pharmaceuticals.

Founded 2020 2-10 employees Grant Total: $40.00K Biotechnology, Health Care +1

General Information

Company Name Pividl Bioscience
Founded Year 2020
Employees 2-10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Pividl Bioscience. To contact Pividl Bioscience, visit pividl.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Pividl Bioscience

Pividl Bioscience is a nanobiotechnology firm that was founded in 2020. The company is pioneering patented platform technologies with cross-sector applications in health, wellness, consumer goods, agrifood, and pharmaceuticals. Their innovative approach has attracted the attention of investors, with the latest grant investment coming from Cultivator on 13th February 2024. As a venture capital firm, Pividl Bioscience presents an intriguing investment opportunity in the rapidly growing biotechnology and health care sectors. The company's wide-ranging applications across various industries position it favorably for potential market disruption and significant returns. With a strong emphasis on patent-protected technologies, Pividl Bioscience demonstrates a commitment to intellectual property and innovation, which can be attractive to investors seeking long-term value and competitive advantage in their portfolio. The versatile nature of Pividl Bioscience's platform technologies opens up possibilities for partnerships and collaborations across multiple sectors, expanding its potential impact and revenue streams. This presents a promising outlook for investors looking to diversify their portfolio with exposure to disruptive technologies with applications in healthcare, consumer goods, and agriculture. Moreover, the recent investment from Cultivator signifies outside validation and support, further adding to the company's credibility and growth potential. In conclusion, Pividl Bioscience's innovative platform technologies, backed by recent investment and partnerships, position it as an exciting prospect for venture capital firms seeking to invest in groundbreaking biotechnology ventures with significant potential for widespread impact and scalability.

Taxonomy: nanobiotechnology, platform technologies, health and wellness, consumer goods, agrifood, pharmaceuticals, patented technologies, biotech firm, healthcare innovations, cross-sector applications, biopharmaceuticals, biotech research, consumer packaged goods, innovative technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Cultivator
13 Feb 2024
Grant $40.00K 1
Invest Nova Scotia
20 Apr 2023

Pividl Bioscience Alternatives & Competitors

View All Alternatives
Pividl Bioscience vs

Africa's leading digital platform for last mile access to health products and household goods

Series B
191 employees
Consumer Goods, Health Care
Pividl Bioscience vs
Advanced Biotics
Advanced Biotics The Netherlands

Microbiome startup specialisting in postbiotic technologies and next-gen prebiotics. Applications in...

1 employees
Biotechnology, Food and Beverage
Pividl Bioscience vs

We make innovative new products that help people realize the benefits of a ketogenic lifestyle.

Series A
6 employees
Biotechnology, Consumer Goods

FAQ About Pividl Bioscience

A nanobiotechnology firm pioneering patented platform technologies for diverse applications in health, wellness, consumer goods, agrifood, and pharmaceuticals.
Pividl Bioscience was founded in 2020.
Pividl Bioscience operates in Biotechnology, Health Care and Health and Wellness. Its work centres on nanobiotechnology, platform technologies, health and wellness and consumer goods.
Pividl Bioscience has approximately 2-10 employees.
Pividl Bioscience has completed 2 funding rounds, raising a total of $40.00K. The latest funding stage is Grant.
Top alternatives and competitors to Pividl Bioscience include Kasha Global, Inc., Advanced Biotics, Disruptive Enterprises, LLC, Intarcia Therapeutics, Inc., ImmunAbs Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pividl Bioscience and Kasha Global, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pividl Bioscience, https://bouncewatch.com/company/pividl-bioscience, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes